Literature DB >> 28224615

Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.

Greta Carioli1, Eva Negri2, Daisuke Kawakita3,4, Werner Garavello5, Carlo La Vecchia1, Matteo Malvezzi1,2.   

Abstract

Nasopharyngeal cancer (NPC) mortality shows great disparity between endemic high risk areas, where non-keratinizing carcinoma (NKC) histology is prevalent, and non-endemic low risk regions, where the keratinizing squamous cell carcinoma (KSCC) type is more frequent. We used the World Health Organization database to calculate NPC mortality trends from 1970 to 2014 in several countries worldwide. For the European Union (EU), the United States (US) and Japan, we also predicted trends to 2020. In 2012, the highest age-standardized (world standard) rates were in Hong Kong (4.51/100,000 men and 1.15/100,000 women), followed by selected Eastern European countries. The lowest rates were in Northern Europe and Latin America. EU rates were 0.27/100,000 men and 0.09/100,000 women, US rates were 0.20/100,000 men and 0.08/100,000 women and Japanese rates were 0.16/100,000 men and 0.04/100,000 women. NPC mortality trends were favourable for several countries. The decline was -15% in men and -5% in women between 2002 and 2012 in the EU, -12% in men and -9% in women in the US and about -30% in both sexes in Hong Kong and Japan. The favourable patterns in Europe and the United States are predicted to continue. Changes in salted fish and preserved food consumption account for the fall in NKC. Smoking and alcohol prevalence disparities between sexes and geographic areas may explain the different rates and trends observed for KSCC and partially for NKC. Dietary patterns, as well as improvement in management of the disease, may partly account for the observed trends, too.
© 2017 UICC.

Entities:  

Keywords:  Epstein Barr virus; alcohol; diet; mortality; nasopharyngeal cancer; tobacco

Mesh:

Year:  2017        PMID: 28224615     DOI: 10.1002/ijc.30660

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.

Authors:  Carlos Rodriguez-Galindo; Mark D Krailo; Matthew J Krasin; Li Huang; M Beth McCarville; John Hicks; Farzana Pashankar; Alberto S Pappo
Journal:  J Clin Oncol       Date:  2019-09-25       Impact factor: 44.544

2.  Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.

Authors:  Songbin Guo; Jinling Zhang; Cairong Wei; Zhiyong Lu; Rulong Cai; Danqi Pan; Hanbin Zhang; Baoxia Liang; Zhenfeng Zhang
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-24       Impact factor: 3.333

3.  Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.

Authors:  Nguyen Hoang Viet; Nguyen Quang Trung; Le Thanh Dong; Ly Quoc Trung; J Luis Espinoza
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-03       Impact factor: 4.553

4.  PLAC8 gene knockout increases the radio-sensitivity of xenograft tumors in nude mice with nasopharyngeal carcinoma by promoting apoptosis.

Authors:  Li-Jun Shen; Cheng-Lin Qi; Rui Yang; Mao-Ling Huang; You Zou; Yang Jiang; Jian-Fei Sheng; Yong-Gang Kong; Qing-Quan Hua; Shi-Ming Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 5.  Nasopharyngeal carcinoma: an evolving paradigm.

Authors:  Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-30       Impact factor: 66.675

6.  Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma.

Authors:  Yuxiang Ma; Xi Chen; Ao Wang; Hongyun Zhao; Qingguang Lin; Hua Bao; Yang Zhang; Shaodong Hong; Wanxiangfu Tang; Yan Huang; Yunpeng Yang; Xue Wu; Yang Shao; Wenfeng Fang; Li Zhang
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

7.  Nasopharyngeal carcinoma incidence and mortality in China, 2013.

Authors:  Kuang-Rong Wei; Rong-Shou Zheng; Si-Wei Zhang; Zhi-Heng Liang; Zhu-Ming Li; Wan-Qing Chen
Journal:  Chin J Cancer       Date:  2017-11-09

8.  MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2.

Authors:  Minhua Wu; Xiaoxia Ye; Shengchun Wang; Qinghua Li; Yinxuan Lai; Yanmei Yi
Journal:  Onco Targets Ther       Date:  2017-06-02       Impact factor: 4.147

9.  Trans-vaccenic acid inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via a mitochondrial-mediated apoptosis pathway.

Authors:  Jian Song; Yujie Wang; Xiaoqin Fan; Hanwei Wu; Jinghong Han; Ming Yang; Lu Lu; Guohui Nie
Journal:  Lipids Health Dis       Date:  2019-02-09       Impact factor: 3.876

10.  Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015.

Authors:  Masafumi Kanno; Norihiko Narita; Yasushi Fujimoto; Naohiro Wakisaka; Tomokazu Yoshizaki; Takeshi Kodaira; Chiyoko Makita; Yuichiro Sato; Keisuke Yamazaki; Takanori Wakaoka; Yuzo Shimode; Hiroyuki Tsuji; Ryosuke Kito; Hajime Ishinaga; Seiji Hosokawa; Hiromasa Takakura; Kunihiro Nishimura; Takuma Matoba; Shigeharu Fujieda
Journal:  Cancers (Basel)       Date:  2019-08-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.